Evaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple Sclerosis
Condition: Multiple SclerosisIntervention: Sponsors: University at Buffalo; TEVAEnrolling by invitation - verified December 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials